273 related articles for article (PubMed ID: 33059244)
1. Effects of mesenchymal stem cells transplantation on multiple sclerosis patients.
Barati S; Tahmasebi F; Faghihi F
Neuropeptides; 2020 Dec; 84():102095. PubMed ID: 33059244
[TBL] [Abstract][Full Text] [Related]
2. Beneficial effects of bone marrow-derived mesenchymal stem cell transplantation in a non-immune model of demyelination.
El-Akabawy G; Rashed LA
Ann Anat; 2015 Mar; 198():11-20. PubMed ID: 25660362
[TBL] [Abstract][Full Text] [Related]
3. Potential Therapeutic Features of Human Amniotic Mesenchymal Stem Cells in Multiple Sclerosis: Immunomodulation, Inflammation Suppression, Angiogenesis Promotion, Oxidative Stress Inhibition, Neurogenesis Induction, MMPs Regulation, and Remyelination Stimulation.
Abbasi-Kangevari M; Ghamari SH; Safaeinejad F; Bahrami S; Niknejad H
Front Immunol; 2019; 10():238. PubMed ID: 30842772
[TBL] [Abstract][Full Text] [Related]
4. Effects of mesenchymal stem cell transplantation on spinal cord injury patients.
Tahmasebi F; Barati S
Cell Tissue Res; 2022 Sep; 389(3):373-384. PubMed ID: 35697943
[TBL] [Abstract][Full Text] [Related]
5. A focus on allogeneic mesenchymal stromal cells as a versatile therapeutic tool for treating multiple sclerosis.
Shokati A; Naser Moghadasi A; Nikbakht M; Sahraian MA; Mousavi SA; Ai J
Stem Cell Res Ther; 2021 Jul; 12(1):400. PubMed ID: 34256857
[TBL] [Abstract][Full Text] [Related]
6. Various strategies to improve efficacy of stem cell transplantation in multiple sclerosis: Focus on mesenchymal stem cells and neuroprotection.
Yousefi F; Lavi Arab F; Saeidi K; Amiri H; Mahmoudi M
J Neuroimmunol; 2019 Mar; 328():20-34. PubMed ID: 30557687
[TBL] [Abstract][Full Text] [Related]
7. The potential use of mesenchymal stem cells for the treatment of multiple sclerosis.
Mansoor SR; Zabihi E; Ghasemi-Kasman M
Life Sci; 2019 Oct; 235():116830. PubMed ID: 31487529
[TBL] [Abstract][Full Text] [Related]
8. Mesenchymal stem cells as a treatment for multiple sclerosis: a focus on experimental animal studies.
Lotfy A; Ali NS; Abdelgawad M; Salama M
Rev Neurosci; 2020 Jan; 31(2):161-179. PubMed ID: 31605598
[TBL] [Abstract][Full Text] [Related]
9. The immunomodulatory and neuroprotective effects of mesenchymal stem cells (MSCs) in experimental autoimmune encephalomyelitis (EAE): a model of multiple sclerosis (MS).
Al Jumah MA; Abumaree MH
Int J Mol Sci; 2012; 13(7):9298-9331. PubMed ID: 22942767
[TBL] [Abstract][Full Text] [Related]
10. The Therapeutic Mechanisms of Mesenchymal Stem Cells in MS-A Review Focusing on Neuroprotective Properties.
Gavasso S; Kråkenes T; Olsen H; Evjenth EC; Ytterdal M; Haugsøen JB; Kvistad CE
Int J Mol Sci; 2024 Jan; 25(3):. PubMed ID: 38338644
[TBL] [Abstract][Full Text] [Related]
11. Mesenchymal stem cells do not exert direct beneficial effects on CNS remyelination in the absence of the peripheral immune system.
Salinas Tejedor L; Berner G; Jacobsen K; Gudi V; Jungwirth N; Hansmann F; Gingele S; Prajeeth CK; Baumgärtner W; Hoffmann A; Skripuletz T; Stangel M
Brain Behav Immun; 2015 Nov; 50():155-165. PubMed ID: 26140734
[TBL] [Abstract][Full Text] [Related]
12. Intranasal delivery of SDF-1α-preconditioned bone marrow mesenchymal cells improves remyelination in the cuprizone-induced mouse model of multiple sclerosis.
Beigi Boroujeni F; Pasbakhsh P; Mortezaee K; Pirhajati V; Alizadeh R; Aryanpour R; Madadi S; Ragerdi Kashani I
Cell Biol Int; 2020 Feb; 44(2):499-511. PubMed ID: 31631484
[TBL] [Abstract][Full Text] [Related]
13. Mesenchymal stem cell transplantation in multiple sclerosis.
Cohen JA
J Neurol Sci; 2013 Oct; 333(1-2):43-9. PubMed ID: 23294498
[TBL] [Abstract][Full Text] [Related]
14. Induced Stem Cells as a Novel Multiple Sclerosis Therapy.
Xie C; Liu YQ; Guan YT; Zhang GX
Curr Stem Cell Res Ther; 2016; 11(4):313-20. PubMed ID: 25732737
[TBL] [Abstract][Full Text] [Related]
15. Immunomodulatory characteristics of mesenchymal stem cells and their role in the treatment of multiple sclerosis.
Gharibi T; Ahmadi M; Seyfizadeh N; Jadidi-Niaragh F; Yousefi M
Cell Immunol; 2015 Feb; 293(2):113-21. PubMed ID: 25596473
[TBL] [Abstract][Full Text] [Related]
16. Mesenchymal Stem Cells in Multiple Sclerosis: Recent Evidence from Pre-Clinical to Clinical Studies.
Gugliandolo A; Bramanti P; Mazzon E
Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33212873
[TBL] [Abstract][Full Text] [Related]
17. Mesenchymal stem cells for multiple sclerosis: does neural differentiation really matter?
Uccelli A; Morando S; Bonanno S; Bonanni I; Leonardi A; Mancardi G
Curr Stem Cell Res Ther; 2011 Mar; 6(1):69-72. PubMed ID: 20955153
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic Effects of Physical Exercise and the Mesenchymal Stem Cell Secretome by Modulating Neuroinflammatory Response in Multiple Sclerosis.
González LM; Ospina LN; Sperling LE; Chaparro O; Cucarián JD
Curr Stem Cell Res Ther; 2022; 17(7):621-632. PubMed ID: 34886779
[TBL] [Abstract][Full Text] [Related]
19. Aging restricts the ability of mesenchymal stem cells to promote the generation of oligodendrocytes during remyelination.
Rivera FJ; de la Fuente AG; Zhao C; Silva ME; Gonzalez GA; Wodnar R; Feichtner M; Lange S; Errea O; Priglinger E; O'Sullivan A; Romanelli P; Jadasz JJ; Brachtl G; Greil R; Tempfer H; Traweger A; Bátiz LF; Küry P; Couillard-Despres S; Franklin RJM; Aigner L
Glia; 2019 Aug; 67(8):1510-1525. PubMed ID: 31038798
[TBL] [Abstract][Full Text] [Related]
20. Adult mesenchymal stem cell therapy for myelin repair in multiple sclerosis.
Rivera FJ; Aigner L
Biol Res; 2012; 45(3):257-68. PubMed ID: 23283435
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
